MYTH 1: My doctor wouldn’t have told me about the clinical trial if he/she didn’t think it was in my best interest
Topics: Patients, Myths, Clinical Research
You want to keep your trial on track, but physical distancing and travel restrictions have made it difficult. Fortunately, IMARC has experience providing remote services.
MYTH 1: My doctor wouldn’t have told me about the clinical trial if he/she didn’t think it was in my best interest
Topics: Patients, Myths, Clinical Research
Recently an announcement of a Public Workshop was posted on Federal Register (FR). This workshop, “Accessible Medical Device Labeling in a Standard Content and Format,” is to investigate the growing need for medical devices to be labeled in a clear and concise manner. Currently, there is a lack of direct regulation that defines a standard for medical device labeling. FDA hopes this workshop will begin the process of establishing a standard.
Topics: Patients, Federal Register, Device Labeling, FDA
This question was recently raised by an article published in the Wall Street Journal and a blog published on ieee spectrum. Currently patients cannot have access to the information without going through their healthcare provider. Should industry support patient access to all information pertaining to their medical device?
Topics: Patients, Access to Data, FDA, HIPAA
“More efficient clinical trials translate to reduced barriers to market for safe, innovative medicines, which is the ultimate goal of patients and manufacturers alike”- this statement from a recent article posted on BIO’s website speaks the truth. This is what we’re all after, but the question remains; how do we get there?
Topics: Modernize Clinical Trials, The Biotechnology Industry Organization, Patients